An overview of systematic reviews of herbal medicine for irritable bowel syndrome

H Jun, SJ Ko, K Kim, J Kim, JW Park - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: Irritable bowel syndrome (IBS) is a common disorder with abdominal pain and
bowel habits changes. Herbal medicines (HMs) are frequently used in the treatment of IBS …

Pharmacological mechanism of Shenlingbaizhu formula against experimental colitis

W Yu, G Wang, C Lu, C Liu, L Jiang, Z Jiang, Z Liang… - Phytomedicine, 2022 - Elsevier
Background Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD)
characterized by an overactive immune response and destruction of the colorectal …

A Network Pharmacology‐Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder

M Meng, C Bai, B Wan, L Zhao, Z Li… - BioMed Research …, 2021 - Wiley Online Library
Background and Objective. Irritable bowel syndrome (IBS) is a prevalent disorder of the
gastrointestinal system with complex pathogenesis. Shenling Baizhu powder (SLBZP) is a …

[HTML][HTML] Chinese herbal formula shen-ling-bai-zhu-san to treat chronic gastritis: Clinical evidence and potential mechanisms

W Jin, J Zhong, Y Song, MF Li, SY Song… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Chronic gastritis (CG) is an inflammatory disease of the gastric mucosa.
Shen-ling-bai-zhu san (SLBZS), a traditional Chinese medicine formula, is widely used for …

Application of the data mining algorithm in the clinical guide medical records

XY Liu, JH Li, YH Wang, L Weihan… - World Journal of …, 2022 - journals.lww.com
Objective: This study analyzed the data of the medical cases in the book,“Clinical Guide
Medical records” using a data mining method, to provide a reference for Ye Tianshi's …

Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan

Y Gu, YT Lai, FR Chang, CY Chen - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: Few studies have investigated traditional Chinese medicine (TCM) utilization
patterns for irritable bowel syndrome (IBS), despite the potential benefits of exploring TCM …

[HTML][HTML] 4 种口服中成药治疗腹泻型肠易激综合征的快速卫生技术评估

叶丽亚, 叶尔太, 王煜姣, 邵沁, 林云志… - 中国中西医结合 …, 2023 - zxyxh.whuhzzs.com
目的利用快速卫生技术评估, 对4 种治疗腹泻性肠易激综合征(IBS-D) 的中成药(四神丸,
痛泻宁颗粒, 补脾益肠丸, 参苓白术颗粒) 的安全性, 有效性和经济性进行评估和比较 …

Evaluation of Xiaoyao-san for treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

JH Lee, W Sung, SB Bak, EJ Kim, YW Kim - European Journal of …, 2022 - Elsevier
Introduction Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder,
and Xiaoyao-san (XYS) has been prescribed for gastroenterological and neurological …

Four oral proprietary Chinese medicines for diarrhea irritable bowel syndrome: a rapid health technology assessment

Y Yeertai, W Yujiao, S Qin, LIN Yunzhi… - Chin J Integr Tradit …, 2023 - zxyxhen.whuhzzs.com
Using rapid health technology assessment, we evaluated and compared the efficacy, safety,
and economics of four proprietary Chinese medicines (including Sishen Wan, Tongxiening …